Active Biotech AB (publ)

Active Biotech AB (publ)verified

ACTI.ST

Price:

$5.8

Market Cap:

$15.29B

Active Biotech AB (publ) is a Swedish biotechnology firm focused on developing pharmaceutical treatments for oncology and immunological conditions. Its product pipeline features Tasquinimod, a small molecule immunomodulator currently in Phase Ib/IIa clinical trials for treating multiple myeloma. Another key asset is Laquinimod, an immunomodulator undergoing Phase I development for various inflammatory eye disorders, including uveitis. Additionally, the company is advancing Naptumomab, an anti-cancer immunotherapy, which is in Phase Ib/II clinical trials for individuals with advanced solid tumors. Naptumomab's development and commercialization are managed through a licensing partnership with ...[Read more]

Industry

Biotechnology

IPO Date

2003-12-19

Stock Exchange

STO

Ticker

ACTI.ST

The Enterprise Value as of June 2026 (TTM) for Active Biotech AB (publ) (ACTI.ST) is 15.24B

According to Active Biotech AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 15.24B. This represents a change of -4.30% compared to the average of 15.92B of the last 4 quarters.

Active Biotech AB (publ) (ACTI.ST) Historical Enterprise Value (quarterly & annually)

How has ACTI.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Active Biotech AB (publ) over the last ten years is 10.33B. The current 15.24B Enterprise Value has changed 14.65% with respect to the historical average. Over the past ten years (40 quarters), ACTI.ST's Enterprise Value was at its highest in in the September 2017 quarter at 24.90B. The Enterprise Value was at its lowest in in the December 2023 quarter at 5.89B.

Quarterly (TTM)
Annual

Average

10.33B

Median

11.08B

Minimum

4.55B

Maximum

17.92B

Active Biotech AB (publ) (ACTI.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Active Biotech AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 160.67%

Maximum Annual Enterprise Value = 17.92B

Minimum Annual Increase = -47.08%

Minimum Annual Enterprise Value = 4.55B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20256.13B34.82%
20244.55B-18.22%
20235.56B-44.98%
202210.11B-16.01%
202112.04B-2.65%
202012.37B-15.85%
201914.70B-17.98%
201817.92B160.67%
20176.88B-47.08%
201612.99B-22.50%

Active Biotech AB (publ) (ACTI.ST) Average Enterprise Value

How has ACTI.ST Enterprise Value performed in the past?

The current Enterprise Value of Active Biotech AB (publ) (ACTI.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.42B

5-year avg

7.68B

10-year avg

10.33B

Active Biotech AB (publ) (ACTI.ST) Enterprise Value vs. Peers

How is ACTI.ST’s Enterprise Value compared to its peers?

Active Biotech AB (publ)’s Enterprise Value is greater than Biovica International AB (publ) (-17466661.00), greater than NextCell Pharma AB (83.96M), greater than Pila Pharma AB (publ) (48.97M), greater than Nanologica AB (publ) (133.11M), greater than Iconovo AB (publ) (22.12M), greater than Sprint Bioscience AB (publ) (354.88M), greater than Biosergen AB (-15536848.00), greater than Alligator Bioscience AB (publ) (5.35M), greater than Immunovia AB (publ) (8.17M), greater than Spago Nanomedical AB (publ) (12.69M),

Build a custom stock screener for Active Biotech AB (publ) (ACTI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Active Biotech AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Active Biotech AB (publ) (ACTI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Active Biotech AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Active Biotech AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

What is the 3-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

What is the 5-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

How does the current Enterprise Value for Active Biotech AB (publ) (ACTI.ST) compare to its historical average?